NCT01876108View on ClinicalTrials.gov

The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Fatty LiverLiver DysfunctionInsulin Resistance
Interventions
DRUG

H.pylori eradication (Omeprazole, Amoxicillin, Bismuth subcitrate, Azithromycin)

The regimen consists of Omeprazole (20 mg/BD)+ Amoxicillin (1 g/day)+ Bismuth subcitrate (240 mg/BD)+ Azithromycin (500 mg/BD)for two weeks.

Trial Locations (1)

Unknown

Gastroenterology clinic, Sina Hospital, Tehran

All Listed Sponsors
lead

Tehran University of Medical Sciences

OTHER

NCT01876108 - The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter